MEG3 LncRNA from Exosomes Released from Cancer-Associated Fibroblasts Enhances Cisplatin Chemoresistance in SCLC via a MiR-15a-5p/CCNE1 Axis
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Long non-coding RNAs (lncRNAs) may act as oncogenes in small-cell lung cancer (SCLC). Exosomes containing lncRNAsreleased from cancer-associated fibroblasts (CAF) accelerate tumorigenesis and confer chemoresistance. This studyaimed to explore the action mechanism of the CAF-derived lncRNA maternally expressed gene 3 (MEG3) on cisplatin (DDP) chemoresistanceand cell processes in SCLC. Materials and Methods: Quantitative real-time PCR was conducted to determine the expression levels of MEG3, miR-15a-5p, andCCNE1. Cell viability and metastasis were measured by 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-h-tetrazolium bromide andinvasion assays, respectively. A xenograft tumor model was developed to confirm the effect of MEG3 overexpression on SCLC progressionin vivo. Relationships between miR-15a-5p and MEG3/CCNE1 were predicted using StarBase software and validated bydual luciferase reporter assay. Western blotting was used to determine protein levels. A co-culture model was established to explorethe effects of exosomes on MEG3 expression in SCLC cell lines. Results: MEG3 was overexpressed in SCLC tissues and cells. MEG3 silencing significantly repressed cell viability and metastasis inSCLC. High expression of MEG3 was observed in CAF-derived conditioned medium (CM) and exosomes, and promoted chemoresistanceand cancer progression. Additionally, MEG3 was found to serve as a sponge of miR-15a-5p to mediate CCNE1 expression. Overexpression of miR-15a-5p and knockout of CCNE1 reversed the effects of MEG3 overexpression on cell viability and metastasis. Conclusion: MEG3 lncRNA released from CAF-derived exosomes promotes DDP chemoresistance via regulation of a miR-15a-5p/CCNE1 axis. These findings may provide insight into SCLC therapy.
Abstract
Purpose: Long non-coding RNAs (lncRNAs) may act as oncogenes in small-cell lung cancer (SCLC). Exosomes containing lncRNAsreleased from cancer-associated fibroblasts (CAF) accelerate tumorigenesis and confer chemoresistance. This studyaimed to explore the action mechanism of the CAF-derived lncRNA maternally expressed gene 3 (MEG3) on cisplatin (DDP) chemoresistanceand cell processes in SCLC. Materials and Methods: Quantitative real-time PCR was conducted to determine the expression levels of MEG3, miR-15a-5p, andCCNE1. Cell viability and metastasis were measured by 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-h-tetrazolium bromide andinvasion assays, respectively. A xenograft tumor model was developed to confirm the effect of MEG3 overexpression on SCLC progressionin vivo. Relationships between miR-15a-5p and MEG3/CCNE1 were predicted using StarBase software and validated bydual luciferase reporter assay. Western blotting was used to determine protein levels. A co-culture model was established to explorethe effects of exosomes on MEG3 expression in SCLC cell lines. Results: MEG3 was overexpressed in SCLC tissues and cells. MEG3 silencing significantly repressed cell viability and metastasis inSCLC. High expression of MEG3 was observed in CAF-derived conditioned medium (CM) and exosomes, and promoted chemoresistanceand cancer progression. Additionally, MEG3 was found to serve as a sponge of miR-15a-5p to mediate CCNE1 expression. Overexpression of miR-15a-5p and knockout of CCNE1 reversed the effects of MEG3 overexpression on cell viability and metastasis. Conclusion: MEG3 lncRNA released from CAF-derived exosomes promotes DDP chemoresistance via regulation of a miR-15a-5p/CCNE1 axis. These findings may provide insight into SCLC therapy.
참고문헌 (41)
- Shepshelovich D, "Body mass index(BMI), BMI change, and overall survival in patients with SCLC and NSCLC : a pooled analysis of the International Lung Cancer Consortium", J Thorac Oncol, 14, pp.1594~1607 (2019)
- Temraz S, "Trends in lung cancer incidence in Lebanon by gender and histological type over the period 2005-2008", J Epidemiol Glob Health, 7, pp.161~167 (2017)
- Sabari JK, "Unravelling the biology of SCLC : implications for therapy", Nat Rev Clin Oncol, 14, pp.549~561 (2017)
- Herrmann MK, "Mediastinal radiotherapy after multidrug chemotherapy and prophylactic cranial irradiation in patients with SCLC--treatment results after long-term follow-up and literature overview", Cancer Radiother, 15, pp.81~88 (2011)
- Santaniello A, "Tumour microenvironment and immune evasion in EGFR addicted NSCLC: hurdles and possibilities", Cancers(Basel), 11, pp.1419~ (2019)
- Mashouri L, "Exosomes : composition, biogenesis, and mechanisms in cancer metastasis and drug resistance", Mol Cancer, 18, pp.75~ (2019)
- Deng X, "Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cells", Int J Cancer, 146, pp.1700~1716 (2020)
- Ren J, "Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19", Theranostics, 8, pp.3932~3948 (2018)
- Yan L, "Cancer-associated fibroblasts-derived exosomes-mediated transfer of LINC00355 regulates bladder cancer cell proliferation and invasion", Cell Biochem Funct, 38, pp.257~265 (2020)
- Tong Y, "Tumor-secreted exosomal lncRNA POU3F3 promotes cisplatin resistance in ESCC by inducing fibroblast differentiation into CAFs", Mol Ther Oncolytics, 18, pp.1~13 (2020)
- Zhang J, "Exosomal long noncoding RNAs are differentially expressed in the cervicovaginal lavage samples of cervical cancer patients", J Clin Lab Anal, 30, pp.1116~1121 (2016)
- Narayanan D, "Long non-coding RNAs in pulmonary neuroendocrine neoplasms", Endocr Pathol, 31, pp.254~263 (2020)
- Wu RR, "Role of miR-579-3p in the development of squamous cell lung carcinoma and the regulatory mechanisms", Eur Rev Med Pharmacol Sci, 23, pp.9464~9470 (2019)
- Zeng F, "Linc00173promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression", Oncogene, 39, pp.293~307 (2020)
- Ye M, "TSPAN12 promotes chemoresistance and proliferation of SCLC under the regulation of miR-495", Biochem Biophys Res Commun, 486, pp.349~356 (2017)
- Chava S, "miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma", Mol Oncol, 14, pp.180~196 (2020)
- Wang ZM, "miR-15a-5p suppresses endometrial cancer cell growth via Wnt", β-catenin signaling pathway by inhibiting WNT3A, 2017, pp.21, 4810~4818
- Yuan JH, "Upregulation of SNHG12 accelerates cell proliferation, migration, invasion and restrain cell apoptosis in breast cancer by enhancing regulating SALL4 expression via sponging miR-15a-5p", Neoplasma, 67, pp.861~870 (2020)
- Ni Y, "miR-15a-5p inhibits metastasis and lipid metabolism by suppressing histone acetylation in lung cancer", Free Radic Biol Med, 161, pp.150~162 (2020)
- Ergun S, "Significance of miR-15a-5p and CNKSR3 as novel prognostic biomarkers in nonsmall cell lung cancer", Anticancer Agents Med Chem, 18, pp.1695~1701 (2018)
- Gorski JW, "CCNE1 amplification as a predictive biomarker of chemotherapy resistance in epithelial ovarian cancer", Diagnostics(Basel), 10, pp.279~ (2020)
- Yang R, "The circRNA circAGFG1acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression", Mol Cancer, 18, pp.4~ (2019)
- Zhu W, "Methyltransferase like 3 promotes colorectal cancer proliferation by stabilizing CCNE1mRNA in an m6A-dependent manner", J Cell Mol Med, 24, pp.3521~3533 (2020)
- Liang Y, "Exosomal microRNA-144 from bone marrow-derived mesenchymal stem cells inhibits the progression of non-small cell lung cancer by targeting CCNE1 and CCNE2", Stem Cell Res Ther, 11, pp.87~ (2020)
- Walter RF, "Identification of deregulation of apoptosis and cell cycle in neuroendocrine tumors of the lung via NanoString nCounter expression analysis", Oncotarget, 6, pp.24690~24698 (2015)
- Pu D, "A randomized controlled study of chemotherapy:etoposide combined with oxaliplatin or cisplatin regimens in the treatment of extensive-stage small cell lung cancer in elderly patients", Zhongguo Fei Ai Za Zhi, 16, pp.20~24 (2013)
- Rossman J, "Phase II study of dose-intense chemotherapy with sequential topoisomerase-targeting regimens with irinotecan", oxaliplatin followed by etoposide, Lung Cancer, pp.2011, 72[DOI]
- Zhang Y, "SBF2-AS1 : an oncogenic lncRNA in small-cell lung cancer", J Cell Biochem, 120, pp.15422~15428 (2019)
- Niu Y, "Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2", Mol Cancer, 16, pp.5~ (2017)
- Sun Y, "Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a", Cell Death Dis, 9, pp.85~ (2018)
- Deng R, "MEG3 affects the progression and chemoresistance of T-cell lymphoblastic lymphoma by suppressing epithelial-mesenchymal transition via the PI3K", mTOR pathway, 2019, pp.120, 8144~8153
- Li H, "Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells", J Clin Lab Anal, 34, pp.e23369~ (2020)
- Li L, "MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis", Oncol Rep, 38, pp.1383~1392 (2017)
- Gao Q, "Exosomal lncRNA UCA1from cancer-associated fibroblasts enhances chemoresistance in vulvar squamous cell carcinoma cells", J Obstet Gynaecol Res, 47, pp.73~87 (2021)
- Wang D, "LncRNA LUADT1sponges miR-15a-3p to upregulate Twist1 in small cell lung cancer", BMC Pulm Med, 19, pp.246~ (2019)
- Tommelein J, "Cancer-associated fibroblasts connect metastasis-promoting communication in colorectal cancer", Front Oncol, 5, pp.63~ (2015)
- Paulsson J, "High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer", J Pathol Clin Res, 3, pp.38~43 (2017)
- Cruz-Bermúdez A, "Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-β signaling", Free Radic Biol Med, 130, pp.163~173 (2019)
- Fatima F, "Stem cell-derived exosomes : roles in stromal remodeling, tumor progression, and cancer immunotherapy", Chin J Cancer, 34, pp.541~553 (2015)
- Fan Q, "The emerging role of exosome-derived non-coding RNAs in cancer biology", Cancer Lett, 414, pp.107~115 (2018)
- Becker A, "Extracellular vesicles in cancer : cell-to-cell mediators of metastasis", Cancer Cell, 30, pp.836~848 (2016)
